These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake. Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247 [TBL] [Abstract][Full Text] [Related]
6. The metabolism of glycosaminoglycans is impaired in prion diseases. Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of P53-related apoptosis had no effect on PrP(Sc) accumulation and prion disease incubation time. Engelstein R; Grigoriadis N; Greig NH; Ovadia H; Gabizon R Neurobiol Dis; 2005 Mar; 18(2):282-5. PubMed ID: 15686956 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436 [TBL] [Abstract][Full Text] [Related]
9. Tetracyclines affect prion infectivity. Forloni G; Iussich S; Awan T; Colombo L; Angeretti N; Girola L; Bertani I; Poli G; Caramelli M; Grazia Bruzzone M; Farina L; Limido L; Rossi G; Giaccone G; Ironside JW; Bugiani O; Salmona M; Tagliavini F Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10849-54. PubMed ID: 12149459 [TBL] [Abstract][Full Text] [Related]
10. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034 [TBL] [Abstract][Full Text] [Related]
11. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells. Avrahami D; Dayan-Amouyal Y; Tal S; Mincberg M; Davis C; Abramsky O; Gabizon R J Neurosci Res; 2008 Sep; 86(12):2753-62. PubMed ID: 18478553 [TBL] [Abstract][Full Text] [Related]
12. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Schulz-Schaeffer WJ; Tschöke S; Kranefuss N; Dröse W; Hause-Reitner D; Giese A; Groschup MH; Kretzschmar HA Am J Pathol; 2000 Jan; 156(1):51-6. PubMed ID: 10623653 [TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction. Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737 [TBL] [Abstract][Full Text] [Related]
15. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc). Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785 [TBL] [Abstract][Full Text] [Related]
16. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K]. Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162 [TBL] [Abstract][Full Text] [Related]
17. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice. Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027 [TBL] [Abstract][Full Text] [Related]
18. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030 [TBL] [Abstract][Full Text] [Related]